0001181431-13-015378.txt : 20130307 0001181431-13-015378.hdr.sgml : 20130307 20130307164934 ACCESSION NUMBER: 0001181431-13-015378 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130305 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamill John CENTRAL INDEX KEY: 0001559058 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13673990 MAIL ADDRESS: STREET 1: 4092 NEW HOPE ROAD CITY: FURLONG STATE: PA ZIP: 18925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd373173.xml HAMILL FORM 4 X0306 4 2013-03-05 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001559058 Hamill John 400 CROSSING BLVD 3RD FLOOR BRIDGEWATER NJ 08807 0 1 0 0 SVP, CFO Common Stock 103613 D Option to Purchase Common Stock 0.94 2013-03-05 4 A 0 110000 0 A 2023-03-05 Common Stock 110000 110000 D These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013. Philip K. Yachmetz as attorney-in-fact for John Hamill 2013-03-07